Home

Recent Articles from StockStory

StockStory is a financial technology company dedicated to simplifying profitable stock investing for individual investors. By leveraging advanced AI technology and human expertise, it generates detailed, data-driven research reports and monthly stock picks to identify high-quality stocks with strong growth potential. The company aims to democratize access to sophisticated analytical methods and proprietary datasets—previously exclusive to elite hedge funds—delivering clear, actionable insights rather than complex, do-it-yourself tools. With a mission to level the playing field in a market often favoring large institutions, StockStory provides retail investors with the resources to make informed, market-beating investment decisions.

Why Hertz (HTZ) Stock Is Up Today
Shares of global car rental company Hertz (NASDAQ:HTZ) jumped 57.9% in the pre-market session after reports revealed that Bill Ackman's Pershing Square had an even bigger stake in the company, a day after the hedge fund acquired $46.5m of the company's stock. Notably, CNBC reported that Pershing Square's total position was about 19.8%, including shares and swaps, making it the company's second-largest shareholder.
Via StockStory · April 17, 2025
Why Insteel (IIIN) Stock Is Trading Up Today
Shares of steel wire manufacturer Insteel (NYSE:IIIN) jumped 11.9% in the morning session after the company reported impressive first-quarter 2025 (fiscal Q2) results, which significantly blew past analysts' sales, EPS and EBITDA estimates. 
Via StockStory · April 17, 2025
Why Badger Meter (BMI) Stock Is Up Today
Shares of water control and measure company Badger Meter (NYSE:BMI) jumped 7% in the morning session after the company reported impressive first quarter 2025 results which exceeded analysts' revenue and EPS estimates. Sales rose 13% year-on-year, fueled primarily by a 16% gain in utility water sales. Margins also expanded meaningfully due to a more favorable product and customer mix. While the company did not issue formal guidance, management acknowledged that the second quarter would face tougher comparisons, yet reaffirmed confidence in long-term growth. Overall, we think this was a solid quarter with some key areas of upside.
Via StockStory · April 17, 2025
ManpowerGroup (MAN) Stock Trades Down, Here Is Why
Shares of workforce solutions provider ManpowerGroup (NYSE:MAN) fell 15.9% in the morning session after the company reported underwhelming first quarter 2025 results: Its EBITDA and EPS missed Wall Street's expectations. 
Via StockStory · April 17, 2025
Why Is Eli Lilly (LLY) Stock Rocketing Higher Today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 15.3% in the morning session after results from a Phase 3 trial showed that its experimental drug, Orforglipron, performed significantly well in helping patients manage obesity and diabetes. The stock's reaction suggested that investors were optimistic that, if approved, Lilly could scale production quickly and tap into the fast-growing diabetes and obesity markets.
Via StockStory · April 17, 2025
Why UnitedHealth (UNH) Shares Are Falling Today
Shares of health insurance company UnitedHealth (NYSE:UNH) fell 22.9% in the morning session after the company reported underwhelming first-quarter 2025 results as its sales and profits fell below Wall Street expectations. 
Via StockStory · April 17, 2025
Why Humana (HUM) Shares Are Getting Obliterated Today
Shares of health insurance company Humana (NYSE:HUM) fell 15.3% in the pre-market session after peer UnitedHealth reported underwhelming first-quarter 2025 results as its sales and profits fell below Wall Street expectations. Guidance was the biggest concern. UNH's new full-year earnings forecast came in well below what analysts had been expecting, mainly because the company saw its care (medical costs in its privately run Medicare plans) and funding issues lasting longer. The news cast a shadow over other health insurers with similar offerings, hinting at tighter margins and more uncertainty ahead.
Via StockStory · April 17, 2025
Why Snap-on (SNA) Shares Are Getting Obliterated Today
Shares of professional tools and equipment manufacturer Snap-on (NYSE:SNA) fell 8.6% in the morning session after the company reported weak first-quarter 2025 results: Its revenue missed significantly, and its EPS fell short of Wall Street's estimates. The big story was a 3.5% drop in sales, with most of that coming from weaker demand in the U.S. Tools Group. Overall, this quarter could have been better.
Via StockStory · April 17, 2025
1 Small-Cap Stock to Own for Decades and 2 to Steer Clear Of
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · April 17, 2025
2 S&P 500 Stocks with Exciting Potential and 1 to Think Twice About
While the S&P 500 includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · April 17, 2025
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · April 17, 2025
1 S&P 500 Stock for Long-Term Investors and 2 to Turn Down
While the S&P 500 includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · April 17, 2025
3 of Wall Street’s Favorite Stocks Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Via StockStory · April 17, 2025
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · April 17, 2025
3 of Wall Street’s Favorite Stocks Showing Warning Signs
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · April 17, 2025
Badger Meter’s (NYSE:BMI) Q1 Earnings Results: Revenue In Line With Expectations
Water control and measure company Badger Meter (NYSE:BMI) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 13.2% year on year to $222.2 million. Its GAAP profit of $1.30 per share was 26.4% above analysts’ consensus estimates.
Via StockStory · April 17, 2025
ManpowerGroup’s (NYSE:MAN) Q1: Beats On Revenue But Stock Drops
Workforce solutions provider ManpowerGroup (NYSE:MAN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 7.1% year on year to $4.09 billion. Its GAAP profit of $0.12 per share was 76.4% below analysts’ consensus estimates.
Via StockStory · April 17, 2025
D.R. Horton (NYSE:DHI) Misses Q1 Revenue Estimates
Homebuilder (NYSE:DHI) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 15.1% year on year to $7.73 billion. The company’s full-year revenue guidance of $34.05 billion at the midpoint came in 5.8% below analysts’ estimates. Its GAAP profit of $2.58 per share was 2.5% below analysts’ consensus estimates.
Via StockStory · April 17, 2025
Insteel (NYSE:IIIN) Delivers Strong Q1 Numbers
Steel wire manufacturer Insteel (NYSE:IIIN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 26.1% year on year to $160.7 million. Its GAAP profit of $0.52 per share was 92.6% above analysts’ consensus estimates.
Via StockStory · April 17, 2025
Snap-on (NYSE:SNA) Reports Sales Below Analyst Estimates In Q1 Earnings
Professional tools and equipment manufacturer Snap-on (NYSE:SNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 11% year on year to $1.14 billion. Its GAAP profit of $4.51 per share was 6.4% below analysts’ consensus estimates.
Via StockStory · April 17, 2025
UnitedHealth (NYSE:UNH) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops
Health insurance company UnitedHealth (NYSE:UNH) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 9.8% year on year to $109.6 billion. Its non-GAAP profit of $7.20 per share was 1.3% below analysts’ consensus estimates.
Via StockStory · April 17, 2025
Distribution Solutions (DSGR): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Distribution Solutions would probably like to forget the past six months even happened. The stock dropped 34.1% and now trades at $26.44. This might have investors contemplating their next move.
Via StockStory · April 17, 2025
3 Big Reasons to Love Verra Mobility (VRRM)
What a brutal six months it’s been for Verra Mobility. The stock has dropped 21% and now trades at $21.92, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · April 17, 2025
3 Reasons to Avoid LTH and 1 Stock to Buy Instead
Even during a down period for the markets, Life Time has gone against the grain, climbing to $31.72. Its shares have yielded a 25.7% return over the last six months, beating the S&P 500 by 34.7%. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · April 17, 2025
3 Reasons to Sell YEXT and 1 Stock to Buy Instead
Yext trades at $6.11 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 13.9% while the S&P 500 is down 8.9%. This might have investors contemplating their next move.
Via StockStory · April 17, 2025
Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Merit Medical Systems (NASDAQ:MMSI) and the rest of the medical devices & supplies - cardiology, neurology, vascular stocks fared in Q4.
Via StockStory · April 17, 2025
3 Reasons HRL is Risky and 1 Stock to Buy Instead
Hormel Foods has been treading water for the past six months, recording a small loss of 4.3% while holding steady at $30.21.
Via StockStory · April 17, 2025
3 Reasons CAR is Risky and 1 Stock to Buy Instead
Avis Budget Group trades at $75.35 per share and has stayed right on track with the overall market, losing 6.1% over the last six months while the S&P 500 is down 9%. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 17, 2025
3 Reasons ATRO is Risky and 1 Stock to Buy Instead
Since April 2020, the S&P 500 has delivered a total return of 85%. But one standout stock has more than doubled the market - over the past five years, Astronics has surged 197% to $24 per share. Its momentum hasn’t stopped as it’s also gained 14.1% in the last six months thanks to its solid quarterly results, beating the S&P by 23%.
Via StockStory · April 17, 2025
3 Reasons to Avoid BWXT and 1 Stock to Buy Instead
Over the past six months, BWX’s shares (currently trading at $104.17) have posted a disappointing 16.7% loss while the S&P 500 was down 8.9%. This might have investors contemplating their next move.
Via StockStory · April 17, 2025
Spotting Winners: Papa John's (NASDAQ:PZZA) And Traditional Fast Food Stocks In Q4
Let’s dig into the relative performance of Papa John's (NASDAQ:PZZA) and its peers as we unravel the now-completed Q4 traditional fast food earnings season.
Via StockStory · April 17, 2025
Sanmina (SANM): Buy, Sell, or Hold Post Q4 Earnings?
Since April 2020, the S&P 500 has delivered a total return of 85%. But one standout stock has more than doubled the market - over the past five years, Sanmina has surged 191% to $76.72 per share. Its momentum hasn’t stopped as it’s also gained 12.5% in the last six months, beating the S&P by 21.4%.
Via StockStory · April 17, 2025
Bloomin' Brands (BLMN): Buy, Sell, or Hold Post Q4 Earnings?
Bloomin' Brands has gotten torched over the last six months - since October 2024, its stock price has dropped 54.5% to $7.66 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 17, 2025
Q4 Earnings Roundup: Plexus (NASDAQ:PLXS) And The Rest Of The Electronic Components & Manufacturing Segment
Looking back on electronic components & manufacturing stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Plexus (NASDAQ:PLXS) and its peers.
Via StockStory · April 17, 2025
3 Reasons to Sell BTSG and 1 Stock to Buy Instead
Even during a down period for the markets, BrightSpring Health Services has gone against the grain, climbing to $17.29. Its shares have yielded a 8.7% return over the last six months, beating the S&P 500 by 17.6%. This run-up might have investors contemplating their next move.
Via StockStory · April 17, 2025
3 Reasons to Sell RCL and 1 Stock to Buy Instead
Since October 2024, Royal Caribbean has been in a holding pattern, posting a small loss of 4.1% while floating around $193.01.
Via StockStory · April 17, 2025
Texas Roadhouse (TXRH): 3 Reasons We Love This Stock
Texas Roadhouse has followed the market’s trajectory closely. The stock is down 10.6% to $162.91 per share over the past six months while the S&P 500 has lost 8.9%. This might have investors contemplating their next move.
Via StockStory · April 17, 2025
CoStar (CSGP): Buy, Sell, or Hold Post Q4 Earnings?
Since October 2024, CoStar has been in a holding pattern, posting a small return of 2.1% while floating around $80.01. However, the stock is beating the S&P 500’s 8.9% decline during that period.
Via StockStory · April 17, 2025
Aerospace Stocks Q4 Highlights: Rocket Lab (NASDAQ:RKLB)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how aerospace stocks fared in Q4, starting with Rocket Lab (NASDAQ:RKLB).
Via StockStory · April 17, 2025
Q4 Earnings Highs And Lows: Vimeo (NASDAQ:VMEO) Vs The Rest Of The Digital Media & Content Platforms Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the digital media & content platforms industry, including Vimeo (NASDAQ:VMEO) and its peers.
Via StockStory · April 17, 2025
Benchmark (BHE): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Benchmark would probably like to forget the past six months even happened. The stock dropped 20.7% and now trades at $35.66. This might have investors contemplating their next move.
Via StockStory · April 17, 2025
3 Reasons to Avoid OLPX and 1 Stock to Buy Instead
Olaplex has gotten torched over the last six months - since October 2024, its stock price has dropped 45.5% to $1.14 per share. This may have investors wondering how to approach the situation.
Via StockStory · April 17, 2025
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.
Via StockStory · April 17, 2025
Unpacking Q4 Earnings: Enphase (NASDAQ:ENPH) In The Context Of Other Renewable Energy Stocks
Looking back on renewable energy stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Enphase (NASDAQ:ENPH) and its peers.
Via StockStory · April 17, 2025
Q4 Rundown: EnerSys (NYSE:ENS) Vs Other Renewable Energy Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the renewable energy industry, including EnerSys (NYSE:ENS) and its peers.
Via StockStory · April 17, 2025
Building Materials Stocks Q4 Recap: Benchmarking Carlisle (NYSE:CSL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at building materials stocks, starting with Carlisle (NYSE:CSL).
Via StockStory · April 17, 2025
3 Reasons INGM is Risky and 1 Stock to Buy Instead
Shareholders of Ingram Micro would probably like to forget the past six months even happened. The stock dropped 33.8% and now trades at $16.29. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 17, 2025
Q4 Earnings Roundup: Wolverine Worldwide (NYSE:WWW) And The Rest Of The Footwear Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the footwear stocks, including Wolverine Worldwide (NYSE:WWW) and its peers.
Via StockStory · April 17, 2025
Q4 Earnings Outperformers: Smith & Wesson (NASDAQ:SWBI) And The Rest Of The Leisure Products Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Smith & Wesson (NASDAQ:SWBI) and its peers.
Via StockStory · April 17, 2025
A Look Back at Casino Operator Stocks’ Q4 Earnings: Golden Entertainment (NASDAQ:GDEN) Vs The Rest Of The Pack
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the casino operator stocks, including Golden Entertainment (NASDAQ:GDEN) and its peers.
Via StockStory · April 17, 2025
Transcat (TRNS): Buy, Sell, or Hold Post Q4 Earnings?
Transcat has gotten torched over the last six months - since October 2024, its stock price has dropped 35.3% to $84.55 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · April 17, 2025
Q4 Earnings Highlights: Newmark (NASDAQ:NMRK) Vs The Rest Of The Real Estate Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Newmark (NASDAQ:NMRK) and the rest of the real estate services stocks fared in Q4.
Via StockStory · April 17, 2025
Q4 Earnings Roundup: Freshpet (NASDAQ:FRPT) And The Rest Of The Perishable Food Segment
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Freshpet (NASDAQ:FRPT) and the rest of the perishable food stocks fared in Q4.
Via StockStory · April 17, 2025
Q4 Rundown: Keurig Dr Pepper (NASDAQ:KDP) Vs Other Beverages, Alcohol, and Tobacco Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Keurig Dr Pepper (NASDAQ:KDP) and the best and worst performers in the beverages, alcohol, and tobacco industry.
Via StockStory · April 17, 2025
Q4 Rundown: Sea (NYSE:SE) Vs Other Online Marketplace Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the online marketplace industry, including Sea (NYSE:SE) and its peers.
Via StockStory · April 17, 2025
Traditional Fast Food Stocks Q4 In Review: Yum! Brands (NYSE:YUM) Vs Peers
Looking back on traditional fast food stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Yum! Brands (NYSE:YUM) and its peers.
Via StockStory · April 17, 2025
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Via StockStory · April 17, 2025
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and worst performers in the surgical equipment & consumables - specialty industry.
Via StockStory · April 17, 2025
Q4 Earnings Highlights: Tapestry (NYSE:TPR) Vs The Rest Of The Apparel and Accessories Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the apparel and accessories industry, including Tapestry (NYSE:TPR) and its peers.
Via StockStory · April 17, 2025
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks, starting with Select Medical (NYSE:SEM).
Via StockStory · April 17, 2025
Winners And Losers Of Q4: Rivian (NASDAQ:RIVN) Vs The Rest Of The Automobile Manufacturing Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Rivian (NASDAQ:RIVN) and its peers.
Via StockStory · April 17, 2025
Hospital Chains Stocks Q4 Teardown: Acadia Healthcare (NASDAQ:ACHC) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how hospital chains stocks fared in Q4, starting with Acadia Healthcare (NASDAQ:ACHC).
Via StockStory · April 17, 2025
Spotting Winners: Asana (NYSE:ASAN) And Productivity Software Stocks In Q4
Looking back on productivity software stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Asana (NYSE:ASAN) and its peers.
Via StockStory · April 17, 2025
Finance and HR Software Stocks Q4 Recap: Benchmarking Bill.com (NYSE:BILL)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bill.com (NYSE:BILL) and the best and worst performers in the finance and hr software industry.
Via StockStory · April 17, 2025
Business Process Outsourcing & Consulting Stocks Q4 Highlights: Genpact (NYSE:G)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Genpact (NYSE:G) and its peers.
Via StockStory · April 17, 2025
Software Development Stocks Q4 Results: Benchmarking Datadog (NASDAQ:DDOG)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Datadog (NASDAQ:DDOG) and the rest of the software development stocks fared in Q4.
Via StockStory · April 17, 2025
A Look Back at Data Storage Stocks’ Q4 Earnings: MongoDB (NASDAQ:MDB) Vs The Rest Of The Pack
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the data storage stocks, including MongoDB (NASDAQ:MDB) and its peers.
Via StockStory · April 17, 2025
Vishay Intertechnology, fuboTV, CarMax, Hain Celestial, and VF Corp Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Powell, Quest Resource, AerSale, Asana, and Wayfair Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Carvana, RH, Wendy's, Central Garden & Pet, and e.l.f. Beauty Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Sunrun, Sphere Entertainment, Installed Building Products, AMC Entertainment, and American Airlines Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Applied Industrial, AGCO, Quanex, Lucid, and RXO Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025
Figs, E.W. Scripps, MGM Resorts, European Wax Center, and WillScot Mobile Mini Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment. 
Via StockStory · April 16, 2025